Adverse Reactions to BNT162b2 Mild, Moderate for 5- to 11-Year-Olds 0 11.07.2022 18:10 «La Crosse Tribune» (lacrossetribune.com) MONDAY, July 11, 2022 (HealthDay News) -- Among children aged 5 to 11 years, most reported adverse events to BNT162b2 COVID-19 vaccination are mild-to-moderate, with few reports of myocarditis, according to a study recently published in Pediatrics. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
